mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
AT7867 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.002 |
mRNA |
SB-743921 |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.003 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.003 |
mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.004 |
mRNA |
NVP-231 |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.004 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.004 |
mRNA |
narciclasine |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.004 |
mRNA |
MK 1775 |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.005 |